3rd Annual Rural Health Clinical Congress

CME/CE INFORMATION

3rd Annual Rural Health Clinical Congress

Saturday, November 20, 2021 | Live CME/CE Conference
Broadcast starts at 8:00 AM CT

Individualizing Treatment for Patients With Moderate-to-Severe Asthma: Strategies to
Improve Care and Outcomes in Rural and Underserved Communities

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

custom image

TARGET AUDIENCE
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.

LEARNING OBJECTIVES

Develop patient-centered treatment plans that reflect the latest clinical evidence and guideline recommendations for asthma
Identify appropriate therapy for moderate-to-severe asthma based on current guidelines and individualized patient- and disease-related factors
Discuss strategies for improving asthma care and management in rural and underserved settings, including self-management education and asthma action plans

FACULTY
Meredith C. McCormack, MD, MHS
Associate Professor of Medicine
Medical Director, Pulmonary Function Laboratory
Pulmonary and Critical Care Medicine
Johns Hopkins University
Baltimore, MD

Barbara P. Yawn, MD, MSc, FAAFP
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC CERTIFICATION

custom image

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For physicians claiming ABIM MOC points, your information will be shared through the ACCME’s Program and Activity Reporting System (PARS). Please allow approximately 30 days for your MOC points to appear on your ABIM records.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.25 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine and RME Collaborative adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies (commercial interests). All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Meredith C. McCormack, MD, MHS, has disclosed the following relationships: consultant for GlaxoSmithKline plc and Aridis Pharmaceuticals; royalties from UpToDate.

Barbara P. Yawn, MD, MSc, FAAFP, has nothing to disclose.

Planners and Managers
The planners and managers from RME Collaborative and PIM have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine via email at inquiries@pimed.com.

Improving Liver Cancer Screening in Rural and Underserved Communities:
Early Detection for Better Patient Outcomes

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

LEARNING OBJECTIVES

Implement evidence-based strategies for screening and surveillance to improve early detection of HCC in rural and underserved populations
Evaluate current evidence for treatment to improve personalized management and follow-up care for patients with HCC
Identify strategies to reduce barriers and improve care coordination for HCC patients who reside in rural and underserved communities

FACULTY
Ghassan K. Abou-Alfa, MD, MBA
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell College at Cornell University
New York, NY

Barbara P. Yawn, MD, MSc, FAAFP (Moderator)
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

custom image

ABIM MOC CERTIFICATION

custom image

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Ghassan K. Abou-Alfa, MD, MBA, has disclosed the following relationships: consultant for Adicet Bio, AstraZeneca, Alnylam Pharmaceuticals, Inc., Autem Medical, Bayer AG, BeiGene, Berry Genomics, Cend Therapeutics, Inc., Celgene Corporation, CytomX Therapeutics, Inc., Eisai Co., Ltd., Eli Lilly and Company, Exelixis, Inc., Flatiron Health, Genentech, Inc./Roche, Genoscience Pharma, Helio Health, Incyte Corporation, Ipsen, Legend Biotech, Merck & Co., Inc., Nerviano Medical Sciences, QED Therapeutics, RedHill Biopharma, Ltd., Rafael Pharmaceuticals, Inc., Servier Pharmaceuticals, Silenseed, Ltd., SillaJen, Inc., Sobi, Surface Oncology, TheraBionic, Inc., Vector Pharma, and Yiviva, Inc.; and grant/research support from Arcus Biosciences, Agios Pharmaceuticals, Inc., AstraZeneca, BioNTech SE, Bristol-Myers Squibb, Celgene Corporation, Flatiron Health, Genentech, Inc./Roche, Genoscience Pharma, Incyte Corporation, Polaris Pharmaceuticals, Inc., Puma Biotechnology, Inc., QED Therapeutics, Silenseed, Ltd., and Yiviva, Inc.

Barbara P. Yawn, MD, MSc, FAAFP, has nothing to disclose.

Planners and Managers
The planners and managers from RME Collaborative and PIM have nothing to disclose.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine via email at inquiries@pimed.com.

HCV Management in Primary Care: Closing Treatment Gaps in
Rural and Underserved Communities

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

LEARNING OBJECTIVES

Differentiate between available treatment regimens for HCV based on their clinical safety and efficacy
Apply current treatment recommendations and the latest clinical evidence to appropriately treat patients with HCV
Implement strategies to overcome barriers and improve multidisciplinary HCV care in rural and underserved communities

FACULTY
Nancy S. Reau, MD, FAASLD, AGAF
Richard B. Capps Chair of Hepatology
Professor, Department of Internal Medicine
Division of Digestive Diseases and Nutrition
Rush Medical College
Section Chief of Hepatology
Associate Director of Organ Transplantation
Rush University Medical Center
Chicago, IL

Barbara P. Yawn, MD, MSc, FAAFP (Moderator)
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

ABIM MOC CERTIFICATION

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Nancy S. Reau, MD, FAASLD, AGAF, has disclosed the following relationships: consultant for AbbVie, Inc., Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., and Merck & Co., Inc.; grant/research support from GENFIT, Intercept Pharmaceuticals, Inc., and Shire Pharmaceuticals.

Barbara P. Yawn, MD, MSc, FAAFP, has nothing to disclose.

Planners and Managers
The planners and managers from RME Collaborative and PIM have nothing to disclose.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine via email at inquiries@pimed.com.

Raising Awareness of Uterine Fibroids: A Patient-Centered Approach to
Optimize Outcomes in Rural and Underserved Settings

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

LEARNING OBJECTIVES

Recognize the signs and symptoms of uterine fibroids to improve timely diagnosis
Integrate an individualized approach for treatment of uterine fibroids based on current evidence, symptoms, and patient preferences
Utilize strategies for improving care for patients with uterine fibroids in rural and underserved areas

FACULTY
Hugh S. Taylor, MD
Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences
Professor of Molecular, Cellular, and Developmental Biology
Chair of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine
Chief of Obstetrics and Gynecology, Yale-New Haven Hospital
New Haven, CT

Barbara P. Yawn, MD, MSc, FAAFP (Moderator)
Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

JOINT ACCREDITATION STATEMENT

ABIM MOC CERTIFICATION

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Hugh S. Taylor, MD, has nothing to disclose.

Barbara P. Yawn, MD, MSc, FAAFP, has nothing to disclose.

Planners and Managers
The planners and managers from RME Collaborative and PIM have nothing to disclose.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine via email at inquiries@pimed.com.

Cardiovascular Disease Management in Rural and Underserved Communities: Increasing Recognition,
Individualizing Targets, and Tailoring Treatment

Jointly provided by the Endocrine Society, Postgraduate Institute for Medicine, and RME Collaborative:

custom image

LEARNING OBJECTIVES

Implement evidence-based assessment strategies to improve the early recognition and diagnosis of heart failure
Evaluate evolving treatment approaches for the management of patients with dyslipidemia and heart failure
Select appropriate treatment for patients with cardiovascular disease based on the latest guideline recommendations, clinical evidence, and patient characteristics
Discuss strategies for reducing disparities and improving access to cardiology care for patients in rural and underserved areas

FACULTY
Akshay S. Desai, MD, MPH
Associate Professor
Harvard Medical School
Director, Cardiomyopathy and Heart Failure Program
Brigham and Women’s Hospital
Boston, MA

Dana E. King, MD (Moderator)
Clinical Provider
Atrium Health, Wake Forest Baptist
Winston-Salem, NC

ACCREDITATION STATEMENT

custom image

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society and Postgraduate Institute for Medicine. Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Endocrine Society designates each activity in this course for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

ABIM MOC CERTIFICATION

CONTINUING NURSING EDUCATION

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

Faculty
The faculty reported the following financial relationship(s) during the content development process for this activity:

Akshay S. Desai, MD, MPH, has nothing to disclose.

Dana E. King, MD, has nothing to disclose.

Rahaf Al Assil, MD, MHSc, has nothing to disclose.

Planners and Managers
The staff involved in the development of this CME activity reported no relevant financial relationships.

DISCLAIMER
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact the Endocrine Society via email at info@endocrine.org.

Recognition and Treatment of Hyperkalemia in Cardiometabolic Disease:
Improving Care and Overcoming Challenges in Rural and Underserved Communities

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative:

LEARNING OBJECTIVES

Identify patients with or at risk for hyperkalemia based on the presence of risk factors
Evaluate the efficacy and safety of new treatments for hyperkalemia
Develop a treatment plan for patients with hyperkalemia based on the latest guideline recommendations, clinical evidence, and patient characteristics
Employ a multidisciplinary team-based approach to improve the management of hyperkalemia in rural and underserved areas

FACULTY
Akshay S. Desai, MD, MPH
Associate Professor
Harvard Medical School
Director, Cardiomyopathy and Heart Failure Program
Brigham and Women’s Hospital
Boston, MA

Dana E. King, MD (Moderator)
Clinical Provider
Atrium Health, Wake Forest Baptist
Winston-Salem, NC

JOINT ACCREDITATION STATEMENT

ABIM MOC CERTIFICATION

Faculty
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Akshay S. Desai, MD, MPH, has nothing to disclose.

Dana E. King, MD, has nothing to disclose.

Planners and Managers
The planners and managers from RME Collaborative and PIM have nothing to disclose.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

System checker: Must meet all requirements of Digitell Live Events Platform
Operating system: Windows or Macintosh
Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
Hardware: computer, smartphone, or tablet
Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine via email at inquiries@pimed.com.

ACKNOWLEDGEMENT
These activities are supported by independent medical education grants from AbbVie, Inc.; AstraZeneca Pharmaceuticals; Eisai, Inc.; Genentech, a member of the Roche Group; Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.; Novartis Pharmaceutical Corporation; and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

COPYRIGHT
©RME Collaborative, a division of Talem Health, LLC 2021. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.